Show simple item record

dc.contributor.authorWorld Health Organization
dc.contributor.authorShubber, Zara
dc.contributor.authorCalmy, Alexandra
dc.contributor.authorAndrieux-Meyer, Isabelle
dc.contributor.authorVitoria, Marco
dc.contributor.authorRenaud-Thery, Francoise
dc.contributor.authorHargreaves, Sally
dc.contributor.authorMills, Edward J
dc.contributor.authorFord, Nathan
dc.coverage.spatialGenevaen
dc.date.accessioned2013-11-07T16:16:50Z
dc.date.available2013-11-07T16:16:50Z
dc.date.issued2013
dc.identifier.govdocWHO/HIV/2013.52
dc.identifier.urihttp://www.who.int/iris/handle/10665/93527
dc.description3 p.en
dc.language.isoenen
dc.publisherWorld Health Organizationen
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshNevirapine
dc.subject.meshHIV Infections
dc.subject.meshReview
dc.subject.meshMeta-Analysis
dc.subject.meshBenzoxazines
dc.titleAdverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysisen
dc.typeTechnical documentsen
dc.subject.meshqualifieradverse effects
dc.subject.meshqualifierdrug therapy
dc.subject.meshqualifieradministration and dosage


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record